A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach

To study bidirectional change and predictors of change in estimated glomerular filtration rate (GFR) and proteinuria in lupus nephritis (LN) using a multistate modeling approach.

[1]  Caroline Gordon,et al.  The frequency and outcome of lupus nephritis: results from an international inception cohort study. , 2016, Rheumatology.

[2]  D. Gladman,et al.  Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study , 2015, Arthritis & rheumatology.

[3]  I. Bruce,et al.  Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort , 2014, Annals of the rheumatic diseases.

[4]  C. Gordon,et al.  The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002–2004: The Georgia Lupus Registry , 2014, Arthritis & rheumatology.

[5]  Caroline Gordon,et al.  Population‐Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program , 2014, Arthritis & rheumatology.

[6]  S. Quaglini,et al.  Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years , 2013, Lupus.

[7]  J. López-Gómez,et al.  Risk Factors for Renal Failure in Patients with Lupus Nephritis: Data from the Spanish Registry of Glomerulonephritis , 2012, Nephron Extra.

[8]  JD Frankovich,et al.  European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort , 2012, Lupus.

[9]  S. Sangle,et al.  Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis , 2012, Lupus.

[10]  R. Saxena,et al.  A Retrospective Analysis of Clinical Presentation of Lupus Nephritis , 2011, The American journal of the medical sciences.

[11]  D. Isenberg,et al.  Assessment of a lupus nephritis cohort over a 30-year period. , 2011, Rheumatology.

[12]  M Alan Brookhart,et al.  Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. , 2011, Arthritis and rheumatism.

[13]  D. Gladman,et al.  Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. , 2011, Kidney international.

[14]  EJ Lewis,et al.  The prognosis of severe lupus nephritis based on the Modification of Diet in Renal Disease (MDRD) Study estimated glomerular filtration rate , 2011, Lupus.

[15]  B. Tom,et al.  Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[16]  I. Bruce,et al.  Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. , 2008, Arthritis and rheumatism.

[17]  I. Bruce,et al.  Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. , 2008, Arthritis and rheumatism.

[18]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[19]  Atsuhiro Kanno,et al.  Predictive Factors of Clinical Outcome in Patients with Diffuse Proliferative Lupus Nephritis Treated Early by Intravenous Methylprednisolone Pulse Therapy , 2007, Renal failure.

[20]  D. Isenberg,et al.  Systemic Lupus International Collaborating Group—onwards and upwards? , 2006, Lupus.

[21]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[22]  B. Astor,et al.  Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. , 2004, The Journal of rheumatology.

[23]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[24]  J. Merrill,et al.  Dual antibody reactivity to β2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome , 2002, Lupus.

[25]  G. Cooper,et al.  Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States , 2002, Lupus.

[26]  M. Petri,et al.  Baseline characteristics of a multiethnic lupus cohort: PROFILE , 2002, Lupus.

[27]  J. Merrill,et al.  Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. , 1999, Thrombosis and haemostasis.

[28]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[29]  J. Merrill,et al.  High prevalence of antiphospholipid antibodies in patients taking procainamide. , 1997, The Journal of rheumatology.

[30]  Y. Seedat,et al.  The significance of arterial hypertension at the onset of clinical lupus nephritis. , 1997, Postgraduate medical journal.

[31]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[32]  S. Studenski,et al.  Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. , 1992, Archives of internal medicine.

[33]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[34]  M. Urowitz,et al.  Mortality in systemic lupus erythematosus. , 1987, Arthritis and rheumatism.

[35]  L R Muenz,et al.  Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. , 1984, Kidney international.

[36]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[37]  A D GUNN,et al.  Case of Anaphylaxis after Anaesthesia , 1943, British medical journal.

[38]  E. Bonfá,et al.  Antibodies to ribosomal P proteins in lupus nephritis: a surrogate marker for a better renal survival? , 2011, Autoimmunity reviews.

[39]  B. Rovin,et al.  Chapter 42 – Kidney , 2011 .

[40]  D. Franco,et al.  Predictors of end stage renal disease in African Americans with lupus nephritis. , 2010, Bulletin of the NYU hospital for joint diseases.

[41]  I. Bruce,et al.  Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. , 2007, Arthritis and rheumatism.

[42]  S. Quaglini,et al.  Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  M. Merrell,et al.  Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. , 1955, Journal of chronic diseases.